Cargando…
IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes
BACKGROUND: Autophagy induction is an effective approach for OA therapy. IL-1β is one of the major inflammatory cytokines linked to OA pathological progression, and its receptor blockade interrupts OA cartilage destruction. The objective of this study was to decipher the link between autophagy and r...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617669/ https://www.ncbi.nlm.nih.gov/pubmed/31291980 http://dx.doi.org/10.1186/s13075-019-1952-5 |
_version_ | 1783433743712649216 |
---|---|
author | Wang, Fen Liu, Jijie Chen, Xiaolei Zheng, Xinpeng Qu, Ning Zhang, Bing Xia, Chun |
author_facet | Wang, Fen Liu, Jijie Chen, Xiaolei Zheng, Xinpeng Qu, Ning Zhang, Bing Xia, Chun |
author_sort | Wang, Fen |
collection | PubMed |
description | BACKGROUND: Autophagy induction is an effective approach for OA therapy. IL-1β is one of the major inflammatory cytokines linked to OA pathological progression, and its receptor blockade interrupts OA cartilage destruction. The objective of this study was to decipher the link between autophagy and regulatory mechanism of IL-1β and to investigate the effect of IL-1β receptor blockade by IL-1 receptor antagonist (IL-1Ra) combined with or without an autophagy inducer (TAT-Beclin1) on extracellular matrix (ECM) in OA chondrocytes in vitro and in vivo. METHODS: IL-1β-treated rat and human OA chondrocytes were cultured in response to IL-1Ra. The expression and distribution of signal molecules regulating ECM synthesis and autophagy were investigated via western blotting, immunoprecipitation, real-time PCR, immunofluorescence, and transmission electron microscope technique. Furthermore, after intra-articular injection of IL-1Ra, TAT-Beclin1, and a combination of both in a rat OA model established by anterior cruciate ligament transection and medial meniscus resection, the morphological changes of cartilage and related signal molecule expression levels were monitored using H.E., Safranin O-Fast green, and immunohistochemistry staining. RESULTS: Reduced autophagy by IL-1β contributed to ECM degradation, and blockade of IL-1β by IL-1Ra restored autophagy and attenuated ECM degradation in rat and human OA chondrocytes, as well as in a rat OA model. Akt/mTOR/ULK1, Akt/mTOR/NF-κB, and LC3B deacetylation were involved in autophagy regulated by IL-1β. Intra-articular injection of IL-1Ra combined with TAT-Beclin1 was more effective than IL-1Ra alone. CONCLUSIONS: IL-1Ra restored autophagy and attenuated ECM degradation, with an implication that blocking IL-1β combined with enhancing autophagy might be a potential therapeutic strategy for OA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-019-1952-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6617669 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66176692019-07-22 IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes Wang, Fen Liu, Jijie Chen, Xiaolei Zheng, Xinpeng Qu, Ning Zhang, Bing Xia, Chun Arthritis Res Ther Research Article BACKGROUND: Autophagy induction is an effective approach for OA therapy. IL-1β is one of the major inflammatory cytokines linked to OA pathological progression, and its receptor blockade interrupts OA cartilage destruction. The objective of this study was to decipher the link between autophagy and regulatory mechanism of IL-1β and to investigate the effect of IL-1β receptor blockade by IL-1 receptor antagonist (IL-1Ra) combined with or without an autophagy inducer (TAT-Beclin1) on extracellular matrix (ECM) in OA chondrocytes in vitro and in vivo. METHODS: IL-1β-treated rat and human OA chondrocytes were cultured in response to IL-1Ra. The expression and distribution of signal molecules regulating ECM synthesis and autophagy were investigated via western blotting, immunoprecipitation, real-time PCR, immunofluorescence, and transmission electron microscope technique. Furthermore, after intra-articular injection of IL-1Ra, TAT-Beclin1, and a combination of both in a rat OA model established by anterior cruciate ligament transection and medial meniscus resection, the morphological changes of cartilage and related signal molecule expression levels were monitored using H.E., Safranin O-Fast green, and immunohistochemistry staining. RESULTS: Reduced autophagy by IL-1β contributed to ECM degradation, and blockade of IL-1β by IL-1Ra restored autophagy and attenuated ECM degradation in rat and human OA chondrocytes, as well as in a rat OA model. Akt/mTOR/ULK1, Akt/mTOR/NF-κB, and LC3B deacetylation were involved in autophagy regulated by IL-1β. Intra-articular injection of IL-1Ra combined with TAT-Beclin1 was more effective than IL-1Ra alone. CONCLUSIONS: IL-1Ra restored autophagy and attenuated ECM degradation, with an implication that blocking IL-1β combined with enhancing autophagy might be a potential therapeutic strategy for OA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-019-1952-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-10 2019 /pmc/articles/PMC6617669/ /pubmed/31291980 http://dx.doi.org/10.1186/s13075-019-1952-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Wang, Fen Liu, Jijie Chen, Xiaolei Zheng, Xinpeng Qu, Ning Zhang, Bing Xia, Chun IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes |
title | IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes |
title_full | IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes |
title_fullStr | IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes |
title_full_unstemmed | IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes |
title_short | IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes |
title_sort | il-1β receptor antagonist (il-1ra) combined with autophagy inducer (tat-beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617669/ https://www.ncbi.nlm.nih.gov/pubmed/31291980 http://dx.doi.org/10.1186/s13075-019-1952-5 |
work_keys_str_mv | AT wangfen il1breceptorantagonistil1racombinedwithautophagyinducertatbeclin1isaneffectivealternativeforattenuatingextracellularmatrixdegradationinratandhumanosteoarthritischondrocytes AT liujijie il1breceptorantagonistil1racombinedwithautophagyinducertatbeclin1isaneffectivealternativeforattenuatingextracellularmatrixdegradationinratandhumanosteoarthritischondrocytes AT chenxiaolei il1breceptorantagonistil1racombinedwithautophagyinducertatbeclin1isaneffectivealternativeforattenuatingextracellularmatrixdegradationinratandhumanosteoarthritischondrocytes AT zhengxinpeng il1breceptorantagonistil1racombinedwithautophagyinducertatbeclin1isaneffectivealternativeforattenuatingextracellularmatrixdegradationinratandhumanosteoarthritischondrocytes AT quning il1breceptorantagonistil1racombinedwithautophagyinducertatbeclin1isaneffectivealternativeforattenuatingextracellularmatrixdegradationinratandhumanosteoarthritischondrocytes AT zhangbing il1breceptorantagonistil1racombinedwithautophagyinducertatbeclin1isaneffectivealternativeforattenuatingextracellularmatrixdegradationinratandhumanosteoarthritischondrocytes AT xiachun il1breceptorantagonistil1racombinedwithautophagyinducertatbeclin1isaneffectivealternativeforattenuatingextracellularmatrixdegradationinratandhumanosteoarthritischondrocytes |